

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.22400180 |
| 2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.02026075 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 4.02026075 |
| 4 | protein localization to synapse (GO:0035418) | 3.99062565 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.81016626 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.77030407 |
| 7 | vocalization behavior (GO:0071625) | 3.60631918 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.55702207 |
| 9 | desmosome organization (GO:0002934) | 3.49559985 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.48720530 |
| 11 | glucocorticoid biosynthetic process (GO:0006704) | 3.45693142 |
| 12 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.44017947 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.42909937 |
| 14 | regulation of glutamate secretion (GO:0014048) | 3.35730675 |
| 15 | respiratory electron transport chain (GO:0022904) | 3.33803405 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.31597104 |
| 17 | electron transport chain (GO:0022900) | 3.29608666 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.29552193 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.27941711 |
| 20 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.26473696 |
| 21 | glutamate secretion (GO:0014047) | 3.26205188 |
| 22 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.24979378 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 3.23900731 |
| 24 | auditory receptor cell stereocilium organization (GO:0060088) | 3.17226971 |
| 25 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.12252908 |
| 26 | regulation of hippo signaling (GO:0035330) | 3.11407321 |
| 27 | righting reflex (GO:0060013) | 3.09780614 |
| 28 | cullin deneddylation (GO:0010388) | 3.07376604 |
| 29 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.07081727 |
| 30 | neurotransmitter secretion (GO:0007269) | 3.06115822 |
| 31 | cellular ketone body metabolic process (GO:0046950) | 3.04850824 |
| 32 | ketone body metabolic process (GO:1902224) | 3.03146252 |
| 33 | female mating behavior (GO:0060180) | 3.01123326 |
| 34 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.00935694 |
| 35 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.00935694 |
| 36 | skeletal muscle adaptation (GO:0043501) | 2.96158603 |
| 37 | regulation of skeletal muscle contraction (GO:0014819) | 2.92464051 |
| 38 | serotonin metabolic process (GO:0042428) | 2.88717323 |
| 39 | dicarboxylic acid catabolic process (GO:0043649) | 2.86971329 |
| 40 | regulation of protein kinase A signaling (GO:0010738) | 2.86952842 |
| 41 | flavonoid metabolic process (GO:0009812) | 2.84484971 |
| 42 | fear response (GO:0042596) | 2.83726414 |
| 43 | neuron-neuron synaptic transmission (GO:0007270) | 2.81049242 |
| 44 | behavioral response to cocaine (GO:0048148) | 2.81019720 |
| 45 | androgen biosynthetic process (GO:0006702) | 2.80686841 |
| 46 | response to histamine (GO:0034776) | 2.80684591 |
| 47 | biotin metabolic process (GO:0006768) | 2.80194667 |
| 48 | branched-chain amino acid catabolic process (GO:0009083) | 2.79878517 |
| 49 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.78749030 |
| 50 | glutamate receptor signaling pathway (GO:0007215) | 2.78077864 |
| 51 | regulation of synaptic vesicle transport (GO:1902803) | 2.76864058 |
| 52 | regulation of female receptivity (GO:0045924) | 2.76833329 |
| 53 | postsynaptic membrane organization (GO:0001941) | 2.75847663 |
| 54 | intestinal epithelial cell development (GO:0060576) | 2.74866849 |
| 55 | behavioral fear response (GO:0001662) | 2.74145262 |
| 56 | behavioral defense response (GO:0002209) | 2.74145262 |
| 57 | exploration behavior (GO:0035640) | 2.74058893 |
| 58 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.73530145 |
| 59 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.72131287 |
| 60 | neuronal action potential propagation (GO:0019227) | 2.70302321 |
| 61 | cochlea development (GO:0090102) | 2.70149133 |
| 62 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.69565855 |
| 63 | reflex (GO:0060004) | 2.69266354 |
| 64 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.68919906 |
| 65 | diterpenoid biosynthetic process (GO:0016102) | 2.68841733 |
| 66 | chaperone-mediated protein transport (GO:0072321) | 2.68715877 |
| 67 | primary amino compound metabolic process (GO:1901160) | 2.67129694 |
| 68 | neuron recognition (GO:0008038) | 2.65963118 |
| 69 | ATP biosynthetic process (GO:0006754) | 2.65284214 |
| 70 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.65200109 |
| 71 | protein deneddylation (GO:0000338) | 2.63320234 |
| 72 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.62637478 |
| 73 | synaptic transmission, glutamatergic (GO:0035249) | 2.59889437 |
| 74 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.59471472 |
| 75 | kynurenine metabolic process (GO:0070189) | 2.58570692 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 2.58561100 |
| 77 | negative regulation of amino acid transport (GO:0051956) | 2.58532396 |
| 78 | dopamine transport (GO:0015872) | 2.58494779 |
| 79 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.58413835 |
| 80 | striated muscle atrophy (GO:0014891) | 2.58403332 |
| 81 | cardiac right ventricle morphogenesis (GO:0003215) | 2.58137696 |
| 82 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.57598464 |
| 83 | L-phenylalanine metabolic process (GO:0006558) | 2.57598464 |
| 84 | neurotransmitter transport (GO:0006836) | 2.57229049 |
| 85 | neuromuscular synaptic transmission (GO:0007274) | 2.56499967 |
| 86 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.55741925 |
| 87 | behavioral response to ethanol (GO:0048149) | 2.54103082 |
| 88 | regulation of oxidative phosphorylation (GO:0002082) | 2.53417868 |
| 89 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.53383042 |
| 90 | regulation of postsynaptic membrane potential (GO:0060078) | 2.52334540 |
| 91 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.52249967 |
| 92 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.51519543 |
| 93 | ubiquinone biosynthetic process (GO:0006744) | 2.51066587 |
| 94 | long-term synaptic potentiation (GO:0060291) | 2.49987054 |
| 95 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.49081202 |
| 96 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.48493550 |
| 97 | presynaptic membrane assembly (GO:0097105) | 2.47100897 |
| 98 | L-methionine salvage (GO:0071267) | 2.46998828 |
| 99 | L-methionine biosynthetic process (GO:0071265) | 2.46998828 |
| 100 | amino acid salvage (GO:0043102) | 2.46998828 |
| 101 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.46271267 |
| 102 | anterior/posterior axis specification, embryo (GO:0008595) | 2.43882650 |
| 103 | gonadal mesoderm development (GO:0007506) | 2.42886565 |
| 104 | negative regulation of protein localization to cell surface (GO:2000009) | 2.41841805 |
| 105 | fatty acid transmembrane transport (GO:1902001) | 2.41483298 |
| 106 | glucocorticoid metabolic process (GO:0008211) | 2.39742502 |
| 107 | methionine biosynthetic process (GO:0009086) | 2.39435796 |
| 108 | retinal metabolic process (GO:0042574) | 2.39353678 |
| 109 | response to pheromone (GO:0019236) | 2.39319259 |
| 110 | hydrogen ion transmembrane transport (GO:1902600) | 2.38748813 |
| 111 | norepinephrine metabolic process (GO:0042415) | 2.37974549 |
| 112 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.36200872 |
| 113 | positive regulation of membrane potential (GO:0045838) | 2.35397503 |
| 114 | regulation of centriole replication (GO:0046599) | 2.35230415 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 2.35149432 |
| 116 | behavioral response to nicotine (GO:0035095) | 2.34807192 |
| 117 | regulation of neurotransmitter secretion (GO:0046928) | 2.34713949 |
| 118 | regulation of vesicle fusion (GO:0031338) | 2.34430383 |
| 119 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.33760149 |
| 120 | catecholamine transport (GO:0051937) | 2.33385838 |
| 121 | phenylpropanoid metabolic process (GO:0009698) | 2.32869013 |
| 122 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.32703448 |
| 123 | long-term memory (GO:0007616) | 2.32379408 |
| 124 | inner mitochondrial membrane organization (GO:0007007) | 2.32250418 |
| 125 | positive regulation of synapse maturation (GO:0090129) | 2.31915327 |
| 126 | regulation of cell communication by electrical coupling (GO:0010649) | 2.31639096 |
| 127 | muscle atrophy (GO:0014889) | 2.31564562 |
| 128 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.31392963 |
| 129 | tryptophan catabolic process (GO:0006569) | 2.30545046 |
| 130 | indole-containing compound catabolic process (GO:0042436) | 2.30545046 |
| 131 | indolalkylamine catabolic process (GO:0046218) | 2.30545046 |
| 132 | ubiquinone metabolic process (GO:0006743) | 2.29933666 |
| 133 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.29821207 |
| 134 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.29385837 |
| 135 | synaptic transmission, dopaminergic (GO:0001963) | 2.29143416 |
| 136 | transferrin transport (GO:0033572) | 2.29122107 |
| 137 | regulation of synaptic plasticity (GO:0048167) | 2.28056475 |
| 138 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.27942722 |
| 139 | transmission of nerve impulse (GO:0019226) | 2.27938804 |
| 140 | oxidative demethylation (GO:0070989) | 2.27923325 |
| 141 | axonal fasciculation (GO:0007413) | 2.27632283 |
| 142 | locomotory exploration behavior (GO:0035641) | 2.27282291 |
| 143 | negative regulation of amine transport (GO:0051953) | 2.26187202 |
| 144 | branched-chain amino acid metabolic process (GO:0009081) | 2.25724346 |
| 145 | positive regulation of synapse assembly (GO:0051965) | 2.25673543 |
| 146 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.25623640 |
| 147 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.25617379 |
| 148 | oxaloacetate metabolic process (GO:0006107) | 2.25442849 |
| 149 | regulation of lipoprotein metabolic process (GO:0050746) | 2.25416986 |
| 150 | positive regulation of neurotransmitter transport (GO:0051590) | 2.25316748 |
| 151 | signal peptide processing (GO:0006465) | 2.25209256 |
| 152 | oxidative phosphorylation (GO:0006119) | 2.24825225 |
| 153 | keratinocyte development (GO:0003334) | 2.23470631 |
| 154 | short-term memory (GO:0007614) | 2.23161241 |
| 155 | synaptic vesicle endocytosis (GO:0048488) | 2.21779721 |
| 156 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.21302535 |
| 157 | aromatic amino acid family catabolic process (GO:0009074) | 2.21258667 |
| 158 | nephron tubule morphogenesis (GO:0072078) | 2.20284847 |
| 159 | epithelial cell maturation (GO:0002070) | 2.20157166 |
| 160 | nitric oxide biosynthetic process (GO:0006809) | 2.19701307 |
| 161 | plasma membrane repair (GO:0001778) | 2.19588586 |
| 162 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.19490609 |
| 163 | inositol metabolic process (GO:0006020) | 2.19151371 |
| 164 | quaternary ammonium group transport (GO:0015697) | 2.18426317 |
| 165 | neurotransmitter catabolic process (GO:0042135) | 2.18198456 |
| 166 | regulation of acrosome reaction (GO:0060046) | 2.17957279 |
| 167 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.17704463 |
| 168 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.16771796 |
| 169 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.16771796 |
| 170 | coenzyme catabolic process (GO:0009109) | 2.16222158 |
| 171 | regulation of water loss via skin (GO:0033561) | 2.15704476 |
| 172 | amino-acid betaine transport (GO:0015838) | 2.13525885 |
| 173 | carnitine transport (GO:0015879) | 2.13525885 |
| 174 | glomerular basement membrane development (GO:0032836) | 2.13011308 |
| 175 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.12824542 |
| 176 | mesonephros development (GO:0001823) | 2.12591462 |
| 177 | short-chain fatty acid metabolic process (GO:0046459) | 2.11756603 |
| 178 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.11607953 |
| 179 | establishment of skin barrier (GO:0061436) | 2.11146956 |
| 180 | aromatic amino acid family metabolic process (GO:0009072) | 2.11038160 |
| 181 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.10834333 |
| 182 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.10811491 |
| 183 | L-phenylalanine catabolic process (GO:0006559) | 2.10811491 |
| 184 | carnitine shuttle (GO:0006853) | 2.09573223 |
| 185 | prostate gland growth (GO:0060736) | 2.09050538 |
| 186 | aspartate family amino acid catabolic process (GO:0009068) | 2.08864819 |
| 187 | myotube differentiation (GO:0014902) | 2.08732725 |
| 188 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.07630110 |
| 189 | muscle filament sliding (GO:0030049) | 2.07515465 |
| 190 | actin-myosin filament sliding (GO:0033275) | 2.07515465 |
| 191 | response to nitrosative stress (GO:0051409) | 2.06643212 |
| 192 | glutathione derivative biosynthetic process (GO:1901687) | 2.06260644 |
| 193 | glutathione derivative metabolic process (GO:1901685) | 2.06260644 |
| 194 | regulation of keratinocyte proliferation (GO:0010837) | 2.06088606 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 4.19897492 |
| 2 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.63550950 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36700388 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92587392 |
| 5 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.70572880 |
| 6 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.38692832 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.27421492 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.27109265 |
| 9 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.14467996 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.13852616 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.11580447 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05905056 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03435473 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.02803554 |
| 15 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.01272728 |
| 16 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 2.01062033 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98421016 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.96615455 |
| 19 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.94765962 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.92027747 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91123883 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87410208 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.86041412 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.77550563 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77547736 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.77527533 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.77527533 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77393717 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75380052 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74736379 |
| 31 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71748193 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71482449 |
| 33 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.70638481 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.69541034 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.68961978 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68020323 |
| 37 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.67933322 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67057839 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66895150 |
| 40 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62291113 |
| 41 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.59863790 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.58286914 |
| 43 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58208709 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57596850 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50533820 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45473564 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44849064 |
| 48 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41487168 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.40073864 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39177976 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39006997 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38713935 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38587453 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36923783 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36811307 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.36598482 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35210899 |
| 58 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.34497358 |
| 59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.34496199 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32856285 |
| 61 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.32597081 |
| 62 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31259226 |
| 63 | TCF4_23295773_ChIP-Seq_U87_Human | 1.30226375 |
| 64 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.30078892 |
| 65 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.30078892 |
| 66 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.30078892 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29482111 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29063047 |
| 69 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.28966454 |
| 70 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.27117722 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24952558 |
| 72 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23680393 |
| 73 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23146218 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22258915 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19843001 |
| 76 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17151358 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15901590 |
| 78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14741207 |
| 79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14397249 |
| 80 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.14296311 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14086186 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13937871 |
| 83 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13768980 |
| 84 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13768980 |
| 85 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13109572 |
| 86 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.12403380 |
| 87 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.11456292 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10923387 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10474293 |
| 90 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10113202 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09146937 |
| 92 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08858969 |
| 93 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08284602 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.06778972 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06255221 |
| 96 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05705382 |
| 97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05412226 |
| 98 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04709581 |
| 99 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04567702 |
| 100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04174776 |
| 101 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04174776 |
| 102 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03207235 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02650921 |
| 104 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02457205 |
| 105 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.02012680 |
| 106 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01742548 |
| 107 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00521613 |
| 108 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00325025 |
| 109 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00041920 |
| 110 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.99660271 |
| 111 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99311931 |
| 112 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.98351713 |
| 113 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98003842 |
| 114 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.97775579 |
| 115 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.97384332 |
| 116 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.96434801 |
| 117 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95969659 |
| 118 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.94041627 |
| 119 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92889338 |
| 120 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92682296 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92296840 |
| 122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91586363 |
| 123 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.90770128 |
| 124 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.90697681 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90195590 |
| 126 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.90073883 |
| 127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88839887 |
| 128 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88272921 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87332995 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87097025 |
| 131 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86991865 |
| 132 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86256578 |
| 133 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86206432 |
| 134 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86145611 |
| 135 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85800972 |
| 136 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85591796 |
| 137 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85348576 |
| 138 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85348576 |
| 139 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.85050404 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84662038 |
| 141 | JUN_21703547_ChIP-Seq_K562_Human | 0.84608319 |
| 142 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.84274259 |
| 143 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84271078 |
| 144 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83816841 |
| 145 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83524093 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83508238 |
| 147 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83502205 |
| 148 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83385082 |
| 149 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.83141938 |
| 150 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.82898969 |
| 151 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.82223652 |
| 152 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81983366 |
| 153 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.81923035 |
| 154 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.81882087 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81549443 |
| 156 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81500301 |
| 157 | EWS_26573619_Chip-Seq_HEK293_Human | 0.81215817 |
| 158 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81089315 |
| 159 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.80226943 |
| 160 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80166993 |
| 161 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80010358 |
| 162 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.79760909 |
| 163 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.79724962 |
| 164 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79569818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.73987703 |
| 2 | MP0002822_catalepsy | 3.51945756 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.50660970 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 2.61292357 |
| 5 | MP0000383_abnormal_hair_follicle | 2.55530622 |
| 6 | MP0009745_abnormal_behavioral_response | 2.43359448 |
| 7 | MP0003123_paternal_imprinting | 2.35919273 |
| 8 | MP0000579_abnormal_nail_morphology | 2.28135521 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.21900970 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.20379980 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.19541151 |
| 12 | MP0003122_maternal_imprinting | 2.18663602 |
| 13 | MP0004270_analgesia | 2.16682234 |
| 14 | MP0000427_abnormal_hair_cycle | 2.09803603 |
| 15 | MP0010678_abnormal_skin_adnexa | 2.05562381 |
| 16 | MP0002064_seizures | 2.01315235 |
| 17 | MP0006276_abnormal_autonomic_nervous | 1.98743399 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 1.95649523 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.93525204 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 1.92264108 |
| 21 | MP0001529_abnormal_vocalization | 1.91265901 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.90342359 |
| 23 | MP0003011_delayed_dark_adaptation | 1.87284078 |
| 24 | MP0003941_abnormal_skin_development | 1.85987875 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.77391027 |
| 26 | MP0008995_early_reproductive_senescence | 1.76157721 |
| 27 | MP0005423_abnormal_somatic_nervous | 1.76149333 |
| 28 | MP0003878_abnormal_ear_physiology | 1.69455006 |
| 29 | MP0005377_hearing/vestibular/ear_phenot | 1.69455006 |
| 30 | MP0009046_muscle_twitch | 1.66717501 |
| 31 | MP0002736_abnormal_nociception_after | 1.65834285 |
| 32 | MP0002272_abnormal_nervous_system | 1.65604093 |
| 33 | MP0000751_myopathy | 1.63739877 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.58067900 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.51060683 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.49949240 |
| 37 | MP0002098_abnormal_vibrissa_morphology | 1.47896287 |
| 38 | MP0004133_heterotaxia | 1.45526652 |
| 39 | MP0004147_increased_porphyrin_level | 1.45208010 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.43004084 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.42107142 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.38405346 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.35213433 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.33767322 |
| 45 | MP0002796_impaired_skin_barrier | 1.33292097 |
| 46 | MP0004084_abnormal_cardiac_muscle | 1.33067301 |
| 47 | MP0004924_abnormal_behavior | 1.32958871 |
| 48 | MP0005386_behavior/neurological_phenoty | 1.32958871 |
| 49 | MP0002184_abnormal_innervation | 1.31609218 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.31035283 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.29297343 |
| 52 | MP0000372_irregular_coat_pigmentation | 1.28763527 |
| 53 | MP0002234_abnormal_pharynx_morphology | 1.28083395 |
| 54 | MP0005187_abnormal_penis_morphology | 1.27252401 |
| 55 | MP0004233_abnormal_muscle_weight | 1.26688603 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.25493996 |
| 57 | MP0010386_abnormal_urinary_bladder | 1.25130207 |
| 58 | MP0004381_abnormal_hair_follicle | 1.24889439 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.24819050 |
| 60 | MP0002557_abnormal_social/conspecific_i | 1.23781551 |
| 61 | MP0003136_yellow_coat_color | 1.23770905 |
| 62 | MP0000647_abnormal_sebaceous_gland | 1.23178396 |
| 63 | MP0003195_calcinosis | 1.23037428 |
| 64 | MP0001970_abnormal_pain_threshold | 1.22925362 |
| 65 | MP0000778_abnormal_nervous_system | 1.21922784 |
| 66 | MP0003121_genomic_imprinting | 1.18948971 |
| 67 | MP0002938_white_spotting | 1.15946071 |
| 68 | MP0004043_abnormal_pH_regulation | 1.15693773 |
| 69 | MP0001486_abnormal_startle_reflex | 1.15273817 |
| 70 | MP0003283_abnormal_digestive_organ | 1.15062503 |
| 71 | MP0004142_abnormal_muscle_tone | 1.12157226 |
| 72 | MP0000467_abnormal_esophagus_morphology | 1.10227843 |
| 73 | MP0000955_abnormal_spinal_cord | 1.08861053 |
| 74 | MP0001905_abnormal_dopamine_level | 1.08490056 |
| 75 | MP0001485_abnormal_pinna_reflex | 1.07693537 |
| 76 | MP0005670_abnormal_white_adipose | 1.06937386 |
| 77 | MP0000462_abnormal_digestive_system | 1.06600837 |
| 78 | MP0002876_abnormal_thyroid_physiology | 1.05745775 |
| 79 | MP0003806_abnormal_nucleotide_metabolis | 1.05468242 |
| 80 | MP0005503_abnormal_tendon_morphology | 1.05098700 |
| 81 | MP0005248_abnormal_Harderian_gland | 1.03707860 |
| 82 | MP0005085_abnormal_gallbladder_physiolo | 1.03566319 |
| 83 | MP0001661_extended_life_span | 1.01754219 |
| 84 | MP0002653_abnormal_ependyma_morphology | 1.01603440 |
| 85 | MP0004036_abnormal_muscle_relaxation | 0.97609054 |
| 86 | MP0008057_abnormal_DNA_replication | 0.97482320 |
| 87 | MP0000566_synostosis | 0.97337494 |
| 88 | MP0003787_abnormal_imprinting | 0.97129739 |
| 89 | MP0003879_abnormal_hair_cell | 0.97046026 |
| 90 | MP0004085_abnormal_heartbeat | 0.96970438 |
| 91 | MP0005171_absent_coat_pigmentation | 0.96543390 |
| 92 | MP0001188_hyperpigmentation | 0.96393534 |
| 93 | MP0005330_cardiomyopathy | 0.94000386 |
| 94 | MP0002066_abnormal_motor_capabilities/c | 0.92987021 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.92099703 |
| 96 | MP0002108_abnormal_muscle_morphology | 0.91354417 |
| 97 | MP0003119_abnormal_digestive_system | 0.91148254 |
| 98 | MP0005253_abnormal_eye_physiology | 0.90854846 |
| 99 | MP0000377_abnormal_hair_follicle | 0.89835430 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.87599363 |
| 101 | MP0001984_abnormal_olfaction | 0.87402665 |
| 102 | MP0003329_amyloid_beta_deposits | 0.87241170 |
| 103 | MP0000537_abnormal_urethra_morphology | 0.86616543 |
| 104 | MP0000631_abnormal_neuroendocrine_gland | 0.86115264 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.85906013 |
| 106 | MP0002882_abnormal_neuron_morphology | 0.85592126 |
| 107 | MP0001664_abnormal_digestion | 0.85391900 |
| 108 | MP0006035_abnormal_mitochondrial_morpho | 0.85149450 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.85101724 |
| 110 | MP0005083_abnormal_biliary_tract | 0.81428878 |
| 111 | MP0006072_abnormal_retinal_apoptosis | 0.81142531 |
| 112 | MP0003646_muscle_fatigue | 0.80583671 |
| 113 | MP0000762_abnormal_tongue_morphology | 0.80315702 |
| 114 | MP0002269_muscular_atrophy | 0.79821727 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.79234961 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.78610590 |
| 117 | MP0002152_abnormal_brain_morphology | 0.78574692 |
| 118 | MP0005408_hypopigmentation | 0.78495090 |
| 119 | MP0005620_abnormal_muscle_contractility | 0.78052518 |
| 120 | MP0003137_abnormal_impulse_conducting | 0.78035303 |
| 121 | MP0002127_abnormal_cardiovascular_syste | 0.77984347 |
| 122 | MP0002069_abnormal_eating/drinking_beha | 0.77064453 |
| 123 | MP0004019_abnormal_vitamin_homeostasis | 0.76811817 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.76396889 |
| 125 | MP0008872_abnormal_physiological_respon | 0.75399010 |
| 126 | MP0009697_abnormal_copulation | 0.75016641 |
| 127 | MP0000749_muscle_degeneration | 0.74760093 |
| 128 | MP0004272_abnormal_basement_membrane | 0.74590009 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 0.74018502 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.73962901 |
| 131 | MP0003718_maternal_effect | 0.73870693 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.73274756 |
| 133 | MP0000639_abnormal_adrenal_gland | 0.73166086 |
| 134 | MP0008775_abnormal_heart_ventricle | 0.73128983 |
| 135 | MP0004858_abnormal_nervous_system | 0.72873316 |
| 136 | MP0004130_abnormal_muscle_cell | 0.72774373 |
| 137 | MP0004811_abnormal_neuron_physiology | 0.72725917 |
| 138 | MP0003786_premature_aging | 0.72652428 |
| 139 | MP0000747_muscle_weakness | 0.72473260 |
| 140 | MP0010771_integument_phenotype | 0.72356305 |
| 141 | MP0000569_abnormal_digit_pigmentation | 0.71793132 |
| 142 | MP0004087_abnormal_muscle_fiber | 0.71260299 |
| 143 | MP0005332_abnormal_amino_acid | 0.71211331 |
| 144 | MP0005535_abnormal_body_temperature | 0.70963122 |
| 145 | MP0005501_abnormal_skin_physiology | 0.70677857 |
| 146 | MP0001666_abnormal_nutrient_absorption | 0.70447514 |
| 147 | MP0002139_abnormal_hepatobiliary_system | 0.69962789 |
| 148 | MP0003936_abnormal_reproductive_system | 0.69915078 |
| 149 | MP0000750_abnormal_muscle_regeneration | 0.69223956 |
| 150 | MP0002160_abnormal_reproductive_system | 0.68485517 |
| 151 | MP0000627_abnormal_mammary_gland | 0.68386867 |
| 152 | MP0005645_abnormal_hypothalamus_physiol | 0.66985507 |
| 153 | MP0000013_abnormal_adipose_tissue | 0.66716199 |
| 154 | MP0005369_muscle_phenotype | 0.63314725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.76389111 |
| 2 | Myokymia (HP:0002411) | 3.96438780 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 3.91116383 |
| 4 | Concave nail (HP:0001598) | 3.81734606 |
| 5 | Atonic seizures (HP:0010819) | 3.76942181 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.56675202 |
| 7 | Acute encephalopathy (HP:0006846) | 3.43213255 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.25687482 |
| 9 | Hyperventilation (HP:0002883) | 3.25134508 |
| 10 | Focal seizures (HP:0007359) | 3.21770597 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.00262488 |
| 12 | Absence seizures (HP:0002121) | 2.89623460 |
| 13 | Hyporeflexia of lower limbs (HP:0002600) | 2.88183752 |
| 14 | Abnormality of alanine metabolism (HP:0010916) | 2.79951875 |
| 15 | Hyperalaninemia (HP:0003348) | 2.79951875 |
| 16 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.79951875 |
| 17 | Mitochondrial inheritance (HP:0001427) | 2.76296974 |
| 18 | Dialeptic seizures (HP:0011146) | 2.76035125 |
| 19 | Visual hallucinations (HP:0002367) | 2.72471374 |
| 20 | Cerebral edema (HP:0002181) | 2.66251963 |
| 21 | Gaze-evoked nystagmus (HP:0000640) | 2.53114812 |
| 22 | Right ventricular cardiomyopathy (HP:0011663) | 2.52585825 |
| 23 | Bundle branch block (HP:0011710) | 2.52481529 |
| 24 | Amelogenesis imperfecta (HP:0000705) | 2.45287766 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 2.44884533 |
| 26 | Pili torti (HP:0003777) | 2.43565330 |
| 27 | Exercise-induced myalgia (HP:0003738) | 2.42318918 |
| 28 | Increased CSF lactate (HP:0002490) | 2.41547763 |
| 29 | Generalized tonic-clonic seizures (HP:0002069) | 2.39969402 |
| 30 | Decreased circulating renin level (HP:0003351) | 2.31189587 |
| 31 | Febrile seizures (HP:0002373) | 2.28574668 |
| 32 | Pancreatic cysts (HP:0001737) | 2.26217495 |
| 33 | Hyperglycinuria (HP:0003108) | 2.21428999 |
| 34 | Broad-based gait (HP:0002136) | 2.21112141 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 2.19746525 |
| 36 | Proximal tubulopathy (HP:0000114) | 2.15283016 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 2.08280019 |
| 38 | Microglossia (HP:0000171) | 2.08053638 |
| 39 | Syncope (HP:0001279) | 2.07828206 |
| 40 | Septate vagina (HP:0001153) | 2.07677553 |
| 41 | Amblyopia (HP:0000646) | 2.06651916 |
| 42 | Progressive cerebellar ataxia (HP:0002073) | 2.05630833 |
| 43 | Abnormality of nail color (HP:0100643) | 2.05615042 |
| 44 | Hypothermia (HP:0002045) | 2.05384080 |
| 45 | Chromsome breakage (HP:0040012) | 2.02507753 |
| 46 | Exercise intolerance (HP:0003546) | 2.02105168 |
| 47 | Abnormality of the labia minora (HP:0012880) | 2.01665170 |
| 48 | Orthostatic hypotension (HP:0001278) | 2.01524875 |
| 49 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.00767305 |
| 50 | Rimmed vacuoles (HP:0003805) | 2.00674443 |
| 51 | Pheochromocytoma (HP:0002666) | 1.99573724 |
| 52 | Abnormality of glycolysis (HP:0004366) | 1.98872335 |
| 53 | Increased serum pyruvate (HP:0003542) | 1.98872335 |
| 54 | Type II lissencephaly (HP:0007260) | 1.96645965 |
| 55 | Renal cortical cysts (HP:0000803) | 1.96333740 |
| 56 | Delusions (HP:0000746) | 1.95948006 |
| 57 | Areflexia of lower limbs (HP:0002522) | 1.94174225 |
| 58 | Anxiety (HP:0000739) | 1.93772188 |
| 59 | Epileptiform EEG discharges (HP:0011182) | 1.93569927 |
| 60 | Furrowed tongue (HP:0000221) | 1.93526098 |
| 61 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.93165842 |
| 62 | Heart block (HP:0012722) | 1.92525203 |
| 63 | Myotonia (HP:0002486) | 1.91003129 |
| 64 | Hypotrichosis (HP:0001006) | 1.88625937 |
| 65 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.88408826 |
| 66 | Optic disc pallor (HP:0000543) | 1.87503822 |
| 67 | Status epilepticus (HP:0002133) | 1.87153472 |
| 68 | Hyperaldosteronism (HP:0000859) | 1.85321625 |
| 69 | Cerebellar dysplasia (HP:0007033) | 1.85230254 |
| 70 | Hepatocellular necrosis (HP:0001404) | 1.85087719 |
| 71 | Abnormal hair laboratory examination (HP:0003328) | 1.84037218 |
| 72 | Shoulder girdle muscle weakness (HP:0003547) | 1.83648671 |
| 73 | Leukodystrophy (HP:0002415) | 1.83105438 |
| 74 | Hypoplastic left heart (HP:0004383) | 1.82253289 |
| 75 | Hyperkalemia (HP:0002153) | 1.80664920 |
| 76 | Lactic acidosis (HP:0003128) | 1.80129361 |
| 77 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80048206 |
| 78 | Dysdiadochokinesis (HP:0002075) | 1.79206558 |
| 79 | Aplasia involving bones of the extremities (HP:0009825) | 1.79142454 |
| 80 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79142454 |
| 81 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79142454 |
| 82 | Lip pit (HP:0100267) | 1.77556528 |
| 83 | Alopecia of scalp (HP:0002293) | 1.75849816 |
| 84 | Popliteal pterygium (HP:0009756) | 1.75845207 |
| 85 | Calf muscle hypertrophy (HP:0008981) | 1.75699254 |
| 86 | Type I transferrin isoform profile (HP:0003642) | 1.75482303 |
| 87 | Abnormal atrioventricular conduction (HP:0005150) | 1.74995745 |
| 88 | True hermaphroditism (HP:0010459) | 1.74276830 |
| 89 | Congenital sensorineural hearing impairment (HP:0008527) | 1.74219235 |
| 90 | J-shaped sella turcica (HP:0002680) | 1.73934501 |
| 91 | Fetal akinesia sequence (HP:0001989) | 1.73580571 |
| 92 | Unsteady gait (HP:0002317) | 1.73247571 |
| 93 | Hamartoma of the eye (HP:0010568) | 1.72833644 |
| 94 | Hypoplastic labia majora (HP:0000059) | 1.72217085 |
| 95 | Abnormality of renal resorption (HP:0011038) | 1.71954851 |
| 96 | Hypoplasia of the uterus (HP:0000013) | 1.71765346 |
| 97 | Central scotoma (HP:0000603) | 1.71674658 |
| 98 | Increased serum lactate (HP:0002151) | 1.71210429 |
| 99 | Hyperammonemia (HP:0001987) | 1.70491019 |
| 100 | Conjunctival hamartoma (HP:0100780) | 1.70266953 |
| 101 | Irregular epiphyses (HP:0010582) | 1.70072939 |
| 102 | Pancreatic fibrosis (HP:0100732) | 1.68718712 |
| 103 | Muscle stiffness (HP:0003552) | 1.67188695 |
| 104 | Fatigable weakness (HP:0003473) | 1.66857057 |
| 105 | Abnormality of the neuromuscular junction (HP:0003398) | 1.66857057 |
| 106 | Hypsarrhythmia (HP:0002521) | 1.66247056 |
| 107 | X-linked dominant inheritance (HP:0001423) | 1.66153465 |
| 108 | Abnormality of glycine metabolism (HP:0010895) | 1.66048331 |
| 109 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.66048331 |
| 110 | Ankle clonus (HP:0011448) | 1.65626075 |
| 111 | CNS demyelination (HP:0007305) | 1.65618513 |
| 112 | Neuroendocrine neoplasm (HP:0100634) | 1.65314502 |
| 113 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.64987571 |
| 114 | Renal Fanconi syndrome (HP:0001994) | 1.64937744 |
| 115 | Abnormality of the labia majora (HP:0012881) | 1.64766697 |
| 116 | Large for gestational age (HP:0001520) | 1.64565462 |
| 117 | Respiratory failure (HP:0002878) | 1.64326035 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 1.63180552 |
| 119 | Cholecystitis (HP:0001082) | 1.63180552 |
| 120 | Gout (HP:0001997) | 1.62774467 |
| 121 | Palmoplantar hyperkeratosis (HP:0000972) | 1.62755589 |
| 122 | Lethargy (HP:0001254) | 1.62521583 |
| 123 | Myoglobinuria (HP:0002913) | 1.62000246 |
| 124 | Prolonged QT interval (HP:0001657) | 1.61862390 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 1.61468927 |
| 126 | Hypoplastic ischia (HP:0003175) | 1.61169424 |
| 127 | Hyperglycinemia (HP:0002154) | 1.60812304 |
| 128 | Lipid accumulation in hepatocytes (HP:0006561) | 1.60666789 |
| 129 | Abnormality of the calf musculature (HP:0001430) | 1.60078739 |
| 130 | Muscle fiber inclusion bodies (HP:0100299) | 1.59727352 |
| 131 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.59470846 |
| 132 | Type 1 muscle fiber predominance (HP:0003803) | 1.58690939 |
| 133 | Sparse eyelashes (HP:0000653) | 1.57286377 |
| 134 | Male pseudohermaphroditism (HP:0000037) | 1.57062063 |
| 135 | Testicular neoplasm (HP:0010788) | 1.56817596 |
| 136 | Poor suck (HP:0002033) | 1.56692032 |
| 137 | Shawl scrotum (HP:0000049) | 1.55350663 |
| 138 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.54397228 |
| 139 | Absent phalangeal crease (HP:0006109) | 1.53628019 |
| 140 | Gait imbalance (HP:0002141) | 1.52888156 |
| 141 | Depressed nasal tip (HP:0000437) | 1.52736345 |
| 142 | Emotional lability (HP:0000712) | 1.52520939 |
| 143 | Metabolic acidosis (HP:0001942) | 1.52308166 |
| 144 | Abnormality of secondary sexual hair (HP:0009888) | 1.52306157 |
| 145 | Abnormality of the axillary hair (HP:0100134) | 1.52306157 |
| 146 | Abnormal finger flexion creases (HP:0006143) | 1.52234876 |
| 147 | Ketosis (HP:0001946) | 1.52183419 |
| 148 | Medial flaring of the eyebrow (HP:0010747) | 1.52149873 |
| 149 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.52119658 |
| 150 | Hepatic necrosis (HP:0002605) | 1.51131431 |
| 151 | Distal lower limb muscle weakness (HP:0009053) | 1.51067355 |
| 152 | Testicular atrophy (HP:0000029) | 1.50432234 |
| 153 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.50127915 |
| 154 | Generalized aminoaciduria (HP:0002909) | 1.50057975 |
| 155 | Renal salt wasting (HP:0000127) | 1.49855411 |
| 156 | Plantar hyperkeratosis (HP:0007556) | 1.49733100 |
| 157 | Poor eye contact (HP:0000817) | 1.49652287 |
| 158 | Ketoacidosis (HP:0001993) | 1.47590548 |
| 159 | Craniofacial dystonia (HP:0012179) | 1.47133263 |
| 160 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.47107015 |
| 161 | Distal arthrogryposis (HP:0005684) | 1.46335488 |
| 162 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.46160617 |
| 163 | Failure to thrive in infancy (HP:0001531) | 1.44393721 |
| 164 | Hypoplastic heart (HP:0001961) | 1.44345066 |
| 165 | Focal dystonia (HP:0004373) | 1.43813988 |
| 166 | Sudden death (HP:0001699) | 1.43397389 |
| 167 | Nemaline bodies (HP:0003798) | 1.42867356 |
| 168 | Abnormality of the ischium (HP:0003174) | 1.41641996 |
| 169 | Epiphyseal dysplasia (HP:0002656) | 1.41589212 |
| 170 | Increased intramyocellular lipid droplets (HP:0012240) | 1.41559832 |
| 171 | Congenital primary aphakia (HP:0007707) | 1.41076305 |
| 172 | Oligomenorrhea (HP:0000876) | 1.40234910 |
| 173 | Vitreoretinal degeneration (HP:0000655) | 1.40123467 |
| 174 | Torticollis (HP:0000473) | 1.39807106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 4.12308789 |
| 2 | NTRK3 | 4.00420102 |
| 3 | EPHA4 | 3.66603864 |
| 4 | AKT3 | 3.34034917 |
| 5 | CASK | 3.12929091 |
| 6 | MAP3K12 | 2.66997726 |
| 7 | MAP3K9 | 2.56363766 |
| 8 | MST1R | 2.53546733 |
| 9 | NME1 | 2.48096423 |
| 10 | MAP3K4 | 2.32728181 |
| 11 | RPS6KB2 | 2.19359112 |
| 12 | ARAF | 2.14553398 |
| 13 | DAPK2 | 2.09598730 |
| 14 | PIK3CG | 2.03564589 |
| 15 | BMPR1B | 2.00486353 |
| 16 | PBK | 1.97595620 |
| 17 | MAP2K4 | 1.89572660 |
| 18 | MINK1 | 1.88251410 |
| 19 | MAP2K7 | 1.85892995 |
| 20 | PLK2 | 1.82645009 |
| 21 | PNCK | 1.79034512 |
| 22 | KSR1 | 1.65130913 |
| 23 | BCKDK | 1.63972951 |
| 24 | KSR2 | 1.62489315 |
| 25 | MET | 1.62024222 |
| 26 | LATS2 | 1.59930005 |
| 27 | WNK4 | 1.57384433 |
| 28 | DAPK1 | 1.54962461 |
| 29 | WNK3 | 1.53552175 |
| 30 | NEK1 | 1.51310449 |
| 31 | SCYL2 | 1.47172643 |
| 32 | BRAF | 1.46932035 |
| 33 | GRK5 | 1.46845453 |
| 34 | SIK1 | 1.36625959 |
| 35 | MST4 | 1.35374118 |
| 36 | PKN2 | 1.34722524 |
| 37 | EIF2AK1 | 1.33981135 |
| 38 | PTK2B | 1.32618229 |
| 39 | LATS1 | 1.32121829 |
| 40 | OBSCN | 1.28691273 |
| 41 | BCR | 1.27458577 |
| 42 | FER | 1.27153238 |
| 43 | NTRK1 | 1.17242386 |
| 44 | PRKCG | 1.17231395 |
| 45 | OXSR1 | 1.15063677 |
| 46 | TRIB3 | 1.14134881 |
| 47 | PHKG2 | 1.13213479 |
| 48 | PHKG1 | 1.13213479 |
| 49 | MARK1 | 1.12172390 |
| 50 | MAPK13 | 1.10588070 |
| 51 | MYLK | 1.09949766 |
| 52 | INSRR | 1.08041316 |
| 53 | PDK2 | 1.07122079 |
| 54 | ADRBK2 | 1.06618770 |
| 55 | STK39 | 1.05753084 |
| 56 | TRPM7 | 1.02854012 |
| 57 | PDK3 | 1.00485869 |
| 58 | PDK4 | 1.00485869 |
| 59 | CAMK2A | 1.00151149 |
| 60 | ACVR1B | 0.98809888 |
| 61 | NEK6 | 0.97798210 |
| 62 | EPHA2 | 0.97464606 |
| 63 | SIK3 | 0.95428057 |
| 64 | MAPKAPK5 | 0.95409157 |
| 65 | GRK1 | 0.94758918 |
| 66 | EIF2AK3 | 0.92495775 |
| 67 | PAK6 | 0.92182278 |
| 68 | TGFBR1 | 0.91106076 |
| 69 | ILK | 0.90190578 |
| 70 | GRK7 | 0.87405917 |
| 71 | TSSK6 | 0.87220356 |
| 72 | MAP3K2 | 0.84368155 |
| 73 | TTN | 0.83475086 |
| 74 | ADRBK1 | 0.82595076 |
| 75 | STK38L | 0.79925605 |
| 76 | CDK5 | 0.79272423 |
| 77 | FRK | 0.76176867 |
| 78 | BRSK2 | 0.76055665 |
| 79 | TRIM28 | 0.75979656 |
| 80 | PAK3 | 0.75664797 |
| 81 | BMPR2 | 0.75200435 |
| 82 | NUAK1 | 0.74411850 |
| 83 | PLK3 | 0.74132619 |
| 84 | NTRK2 | 0.74012060 |
| 85 | RAF1 | 0.73423576 |
| 86 | CAMK2B | 0.73139014 |
| 87 | CDK19 | 0.72910018 |
| 88 | UHMK1 | 0.70957042 |
| 89 | CAMKK1 | 0.70732722 |
| 90 | PRKD3 | 0.68780190 |
| 91 | RPS6KB1 | 0.67831130 |
| 92 | MAP2K1 | 0.67020357 |
| 93 | CDK18 | 0.66881292 |
| 94 | PRKAA1 | 0.66134077 |
| 95 | DAPK3 | 0.65746659 |
| 96 | CDK14 | 0.64621666 |
| 97 | PRKCI | 0.64102250 |
| 98 | LIMK1 | 0.63243567 |
| 99 | DDR2 | 0.63125485 |
| 100 | MAP4K2 | 0.62987680 |
| 101 | PRKAA2 | 0.62794103 |
| 102 | EEF2K | 0.62066842 |
| 103 | PRKCE | 0.61425539 |
| 104 | PRPF4B | 0.59169740 |
| 105 | WEE1 | 0.59027234 |
| 106 | AKT2 | 0.58177499 |
| 107 | MAPK12 | 0.57831538 |
| 108 | CDK15 | 0.57762170 |
| 109 | PIK3CA | 0.56211324 |
| 110 | TESK1 | 0.55651346 |
| 111 | CAMK1 | 0.55629087 |
| 112 | MAP3K6 | 0.55065955 |
| 113 | STK38 | 0.55065563 |
| 114 | STK3 | 0.54684501 |
| 115 | CAMK2G | 0.54506402 |
| 116 | ERBB3 | 0.53015560 |
| 117 | NME2 | 0.51776252 |
| 118 | TNK2 | 0.51229501 |
| 119 | DMPK | 0.50667199 |
| 120 | CSNK1E | 0.49901476 |
| 121 | DYRK1A | 0.49867829 |
| 122 | MAP2K6 | 0.49849796 |
| 123 | CDK11A | 0.49467733 |
| 124 | FGFR2 | 0.49035618 |
| 125 | ZAK | 0.46994865 |
| 126 | CCNB1 | 0.45767305 |
| 127 | CSNK1A1 | 0.45085077 |
| 128 | EIF2AK2 | 0.44530350 |
| 129 | TNIK | 0.43211015 |
| 130 | PINK1 | 0.42766007 |
| 131 | PRKACB | 0.42375143 |
| 132 | SGK1 | 0.40895155 |
| 133 | MAP3K7 | 0.40714155 |
| 134 | VRK2 | 0.39659255 |
| 135 | CDC42BPA | 0.39583711 |
| 136 | SGK494 | 0.38815105 |
| 137 | SGK223 | 0.38815105 |
| 138 | FGR | 0.38288851 |
| 139 | CAMK2D | 0.37271092 |
| 140 | MAP2K2 | 0.37141980 |
| 141 | CHUK | 0.36934168 |
| 142 | PRKG2 | 0.35836843 |
| 143 | BRSK1 | 0.35050725 |
| 144 | WNK1 | 0.35014460 |
| 145 | PDPK1 | 0.34264610 |
| 146 | PRKACA | 0.34224362 |
| 147 | CSNK1D | 0.34058967 |
| 148 | MELK | 0.33971910 |
| 149 | SGK2 | 0.33969926 |
| 150 | CAMKK2 | 0.31437360 |
| 151 | MAPKAPK3 | 0.29671527 |
| 152 | MAP3K11 | 0.29645993 |
| 153 | PRKCZ | 0.28179087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.46023027 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.07127010 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.80164919 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67026934 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.30477367 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.24407181 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22275613 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11698066 |
| 9 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.07173102 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.04076496 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.03273601 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.98219131 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.94494945 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.86484089 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84346208 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.75365034 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.72500554 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.72358440 |
| 19 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69740665 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69172063 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.60653796 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.54333694 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.50916013 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.49770579 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48333484 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.47033243 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.45667540 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45197563 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.42464406 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40971839 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38975779 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.37621303 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36079027 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.33273698 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32679670 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.32339796 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.32026145 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.30322927 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.25557352 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25519710 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24218286 |
| 42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.24012299 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23971838 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20883716 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.19057277 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18375080 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17811218 |
| 48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.17403837 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.17042345 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16670281 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.15992107 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15492534 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.15458195 |
| 54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.14453989 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 1.12618531 |
| 56 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09804163 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03393654 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03222713 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03126843 |
| 60 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02767313 |
| 61 | Homologous recombination_Homo sapiens_hsa03440 | 1.01718708 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01693341 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 1.00779255 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.99516542 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98840579 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98608261 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98256114 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.97538856 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97345403 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97187584 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.97099823 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.96497710 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96051505 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94060638 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.93816372 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91824551 |
| 77 | Melanogenesis_Homo sapiens_hsa04916 | 0.91714122 |
| 78 | Gap junction_Homo sapiens_hsa04540 | 0.90578134 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87674054 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87576870 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.86334651 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86247457 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84809251 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82475177 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82424775 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80557678 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79050423 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.77340819 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77169970 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75606901 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75190529 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.72181578 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71157226 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70395432 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69631108 |
| 96 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.68963406 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68898863 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68244722 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67678489 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.66230067 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65540805 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65055969 |
| 103 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63404601 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63157975 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.62585793 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.62540276 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61801263 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60602031 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59162049 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58642285 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58409556 |
| 112 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57962642 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57928975 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57323616 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51980965 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51971612 |
| 117 | Bile secretion_Homo sapiens_hsa04976 | 0.51821487 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51786602 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51064079 |
| 120 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50358158 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50346218 |
| 122 | Lysine degradation_Homo sapiens_hsa00310 | 0.50071679 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49943283 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48510161 |
| 125 | Tight junction_Homo sapiens_hsa04530 | 0.46968545 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45924820 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45392391 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44847465 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44579758 |
| 130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43279853 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42569432 |
| 132 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42324403 |
| 133 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41416290 |
| 134 | Axon guidance_Homo sapiens_hsa04360 | 0.41043465 |
| 135 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39278576 |
| 136 | RNA polymerase_Homo sapiens_hsa03020 | 0.38227271 |
| 137 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.37733279 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36885629 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36710763 |
| 140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35424046 |
| 141 | Phototransduction_Homo sapiens_hsa04744 | 0.34492348 |
| 142 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33343935 |

